| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
4
2
1
5
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
2 / 5 Stars
|
|
TheStreet.com
E+
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 0.71 | 0.71 |
| Stocks | 56.29 | 56.29 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 43.0 | 43.0 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Nektar Therapeutics, Inc. | NKTR | 38.6 | 9.57 |
| Advanced Micro Devices Inc | AMD | 34.17 | 2.93 |
| ASOS PLC | ASC | --- | 2.92 |
| Fairchild Semiconductor International Inc | FCS | -11.81 | 2.71 |
| Urban Outfitters Inc. | URBN | 3.91 | 2.67 |
| Cepheid | CPHD | 9.3 | 2.5 |
| Electrocomponents PLC | ECM | --- | 2.49 |
| Sothebys Class A | BID | 0.21 | 2.44 |
| Acacia Research Coroporation | ACTG | -7.73 | 2.43 |
| Carl Zeiss Meditec AG | CZMWF | 2.92 | 2.42 |
